molluSCAN-eye
PrivateLast Round
Seed
Mar 20, 2025
Total Funding Raised
$24,400
Company Overview
molluSCAN-eye operates in Energy & Sustainability and is based in Bordeaux. Its latest recorded funding round was an Accelerator round in May 2021.
molluSCAN-eye is an environmental technology company that provides aquatic biosurveillance solutions using bivalve mollusks as living sentinels to monitor water quality in real-time.
Sector
Energy & Sustainability
Verticals
Environmental Monitoring, Water Treatment, Sensors
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
molluSCAN-eye Comparables
Compare molluSCAN-eye with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Laboratoire Watchfrog | 88% | |
| Blue Sources LLC | 84% | |
| PROTE Technologie dla Środowiska | 83% |
For institutional investors. Book with your work email.
molluSCAN-eye Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Mar 20, 2025 | ||||
| Accelerator | May 1, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
molluSCAN-eye Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Aquitaine Science Transfert | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 15, 2026
Monthly visitors grew 34% MoM, reaching 1.1K.
- May 14, 2026
Monthly visitors grew 34% MoM, reaching 1.1K.
For institutional investors. Book with your work email.
molluSCAN-eye Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about molluSCAN-eye's valuation, stock price, and market status.
Is molluSCAN-eye a public or private company?
molluSCAN-eye is a private company.
What is the current stock price of molluSCAN-eye?
molluSCAN-eye is a private company, so its shares have no public market price. Caplight tracks molluSCAN-eye's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is molluSCAN-eye worth (valuation)?
Valuation information for molluSCAN-eye is not publicly available.
Can I buy molluSCAN-eye stock?
molluSCAN-eye shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was molluSCAN-eye's last funding round?
molluSCAN-eye's most recent funding round was Seed on March 20, 2025.
Who are the main investors in molluSCAN-eye?
Key investors in molluSCAN-eye include Aquitaine Science Transfert.
Will molluSCAN-eye IPO soon?
No public IPO plans have been announced for molluSCAN-eye.
How can I track molluSCAN-eye secondary market activity?
Caplight tracks bids, offers, and trades in molluSCAN-eye's shares on secondary markets.